Cachexia
Muscle-wasting syndrome in chronic disease.
Cachexia is a syndrome tied to certain long-term illnesses, marked by muscle loss that doesn't fully reverse even when nutrition improves. It shows up most often in people with cancer, congestive heart failure, chronic obstructive pulmonary disease, chronic kidney disease, and AIDS. These diseases disrupt how the body manages inflammation, metabolism, and signals from the brain, which over time leads to muscle wasting and other harmful shifts in body composition. Unlike weight loss from simply not eating enough, cachexia primarily targets muscle, and it can occur with or without fat loss. Diagnosing it is tricky because there are no clear-cut guidelines, and how it presents varies from person to person.
Like malnutrition, cachexia tends to worsen health outcomes and lower quality of life. How well someone does depends on the type and severity of their underlying illness, but the outlook is often poor, especially in late-stage disease. Treating the root cause effectively can significantly improve cachexia, but symptom-focused approaches—like nutritional therapy and exercise—usually don’t reverse the syndrome and offer very limited help in advanced cases.
**Definition** Defining cachexia is tough because it often overlaps with malnutrition and sarcopenia. Since no clear rules separate these conditions, experts are still working to agree on definitions to better address nutrition-related problems. In the past, cachexia was described as a complex metabolic syndrome tied to an underlying illness, characterized by muscle loss with or without fat loss. In 2011, experts updated this to call it a multifactorial syndrome defined by ongoing loss of skeletal muscle mass (with or without fat loss) that can’t be fully fixed by standard nutritional support and leads to progressive functional decline. They also proposed three stages: pre-cachexia, cachexia, and refractory cachexia.
**Cachexia and malnutrition** Cachexia and malnutrition are related but not the same. Malnutrition happens when the body doesn’t get enough nutrients, causing changes in weight, physical strength, and mental function. It includes both disease-related malnutrition and non-disease forms like starvation or aging. Cachexia should be seen as a type of malnutrition where inflammation from a long-term illness drives unwanted muscle loss.
**Cachexia and sarcopenia** Cachexia and sarcopenia are
- field
- Medicine
- known_for
- Syndrome of muscle loss in chronic illness
- associated_conditions
- Cancer, congestive heart failure, AIDS, chronic obstructive pulmonary disease, chronic kidney disease
- key_molecules
- Tumor necrosis factor (TNF), interleukin 6 (IL-6), myostatin, activin, GDF-15
Quick Facts
- Field
- Oncology, internal medicine, physical medicine and rehabilitation
- Symptoms
- Sudden weight loss, altered eating signals
- Prognosis
- Very poor
- Frequency
- 1%
- Deaths
- 1.5 to 2 million people a year
Facts from the source article.
Lore & Background
Cachexia is a complex metabolic syndrome associated with underlying illness, characterized by loss of muscle with or without loss of fat mass. In 2011, experts updated the definition to emphasize ongoing loss of skeletal muscle mass that cannot be fully reversed by conventional nutritional support, leading to progressive functional impairment. They proposed three stages: pre-cachexia, cachexia, and refractory cachexia. The syndrome is distinct from malnutrition, though related, as cachexia involves inflammation from long-term illness causing unwanted muscle loss, while malnutrition can occur without disease. Cachexia also differs from sarcopenia, which is caused by aging rather than disease and inflammation.
Reader's Guide
Cachexia is significant because it worsens health outcomes and quality of life for patients with chronic illnesses, and its prognosis is typically poor, especially in late-stage disease. The syndrome can improve with effective treatment of the underlying illness, but symptomatic treatments like nutritional therapy and exercise have very limited benefit in advanced cases. Diagnosis remains difficult due to lack of clear guidelines, and experts continue working to agree on definitions. The mechanisms involve inflammation (via TNF and IL-6), metabolic changes (including lipid mobilizing factor and mitochondrial uncoupling proteins), and hormonal disruptions (such as glucocorticoids, leptin, and parathyroid-related peptide). Scoring systems like the Cachexia Staging Score help categorize severity into non-cachexia, pre-cachexia, cachexia, and refractory cachexia stages.
Did You Know?
- Cachexia causes muscle loss that cannot be fully reversed with improved nutrition.
- It most commonly occurs in cancer, congestive heart failure, AIDS, chronic obstructive pulmonary disease, and chronic kidney disease.
- Tumor necrosis factor (TNF) breaks down muscle and fat by activating the ubiquitin proteasome pathway.
- The Cachexia Staging Score categorizes patients into non-cachexia, pre-cachexia, cachexia, and refractory cachexia stages.
More in Symptoms and signs: Endocrinology, nutrition, and metabolism 1-21
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record